|
US4287341A
(en)
*
|
1979-11-01 |
1981-09-01 |
Pfizer Inc. |
Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
|
|
US6723727B1
(en)
*
|
1996-12-20 |
2004-04-20 |
Hoechst Aktiengesellschaft |
Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
|
|
DE69842109D1
(de)
*
|
1997-08-21 |
2011-03-10 |
Shiseido Co Ltd |
Chinazolin-4-on Derivate, deren Herstellung und deren Verwendung als Haarwuchsmittel oder in äusserlich anzuwendenden Hautpflegemitteln
|
|
AU7734700A
(en)
*
|
1999-10-01 |
2001-05-10 |
Advanced Medicine, Inc. |
Macrocyclic quinazolinones and their use as local anesthetics
|
|
US6667300B2
(en)
*
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
ES2527754T3
(es)
*
|
2000-04-25 |
2015-01-29 |
Icos Corporation |
Inhibidores de la isoforma delta de la fosfatidilinositol 3-quinasa humana
|
|
AUPR201600A0
(en)
*
|
2000-12-11 |
2001-01-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Quinazolinone derivative
|
|
CA2459584A1
(en)
*
|
2001-09-05 |
2003-03-13 |
Cynthia C. Bamdad |
Compositions and use thereof in the treatment of cancer
|
|
WO2003020279A2
(en)
|
2001-09-05 |
2003-03-13 |
Minerva Biotechnologies Corporation |
Compositions and methods of treatment of cancer
|
|
WO2003039460A2
(en)
*
|
2001-11-07 |
2003-05-15 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
|
AUPS019702A0
(en)
*
|
2002-01-29 |
2002-02-21 |
Fujisawa Pharmaceutical Co., Ltd. |
Condensed heterocyclic compounds
|
|
AU2003262747A1
(en)
*
|
2002-08-21 |
2004-03-11 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
EP1558260A4
(en)
*
|
2002-11-04 |
2006-10-25 |
Nps Pharma Inc |
CHINAZOLINONE COMPOUNDS AS CALCILYTIC
|
|
DE602004022819D1
(de)
*
|
2003-06-06 |
2009-10-08 |
Vertex Pharma |
Von atp-bindende kassette transportern
|
|
US20050054614A1
(en)
*
|
2003-08-14 |
2005-03-10 |
Diacovo Thomas G. |
Methods of inhibiting leukocyte accumulation
|
|
US20050043239A1
(en)
*
|
2003-08-14 |
2005-02-24 |
Jason Douangpanya |
Methods of inhibiting immune responses stimulated by an endogenous factor
|
|
LT2612862T
(lt)
|
2004-05-13 |
2017-01-25 |
Icos Corporation |
Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės delta inhibitoriai
|
|
CA2567883A1
(en)
*
|
2004-05-25 |
2005-12-15 |
Icos Corporation |
Methods for treating and/or preventing aberrant proliferation of hematopoietic cells
|
|
EP1885356A2
(en)
*
|
2005-02-17 |
2008-02-13 |
Icos Corporation |
Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
|
|
EP2010505B1
(en)
*
|
2006-03-28 |
2012-12-05 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
|
AU2009313878B2
(en)
|
2008-11-13 |
2016-01-07 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
|
US9492449B2
(en)
|
2008-11-13 |
2016-11-15 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
|
MX2011009955A
(es)
|
2009-03-24 |
2011-11-18 |
Gilead Calistoga Llc |
Atropisomeros de derivados de 2-purinil-3-tolil-quinazolinona y metodos de uso.
|
|
EP2421536B1
(en)
*
|
2009-04-20 |
2015-08-26 |
Gilead Calistoga LLC |
Methods of treatment for solid tumors
|
|
MX2012000817A
(es)
|
2009-07-21 |
2012-05-08 |
Gilead Calistoga Llc |
Tratamiento para desordenes del higado con inhibidores pi3k.
|
|
BRPI1003506B1
(pt)
|
2010-09-24 |
2019-12-03 |
Ache Int Bvi Ltd |
composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
|
|
CA2832822A1
(en)
|
2011-04-10 |
2012-10-18 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
|
UY34656A
(es)
|
2012-03-05 |
2013-10-31 |
Gilead Calistoga Llc |
Polimorfos de (s)?2?(1?(9h?purin?6?ilamino)propil)?5?fluor?3?fenilquinazolin?4(3h)?ona, composición y método de preparación
|
|
AU2013288265B2
(en)
|
2012-07-09 |
2017-04-06 |
Lupin Limited |
Tetrahydroquinazolinone derivatives as PARP inhibitors
|
|
CN105849108A
(zh)
|
2013-12-20 |
2016-08-10 |
吉利德卡利斯托加公司 |
磷脂酰肌醇3-激酶抑制剂的制备方法
|
|
AU2014364414A1
(en)
|
2013-12-20 |
2016-06-30 |
Gilead Calistoga Llc |
Polymorphic forms of a hydrochloride salt of (S) -2-(1-(9H-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3H) -one
|
|
AU2015274696B2
(en)
|
2014-06-13 |
2018-09-27 |
Gilead Sciences, Inc. |
Phosphatidylinositol 3-kinase inhibitors
|